Skip to main content

Table 1 Comparison between 4 weeks pre- and 4 weeks post-TMS treatment as regards clinical data of migraine and MIDAS in the patient group

From: Repetitive transcranial magnetic stimulation as a prophylactic treatment in migraine

 

Pre-TMS, no. = 40

Post-TMS, no. = 40

Test value

P value

No. of headache attacks (days per month)

Median (IQR)

17.00 (16–22.5)

5.00 (2–8)

− 5.515ǂ

< 0.001

Range

7–27

0–25

Duration of individual attack (hours)

Median (IQR)

15.63 (12.5–19.5)

0.25 (0.13–0.53)

− 5.484ǂ

< 0.001

Range

4.75–42

0–19.50

No. of pills (per month)

Median (IQR)

23.00 (15–33)

0.00 (0–1)

− 5.345ǂ

< 0.001

Range

0–79

0–33

Pain intensity

Median (IQR)

7.50 (7.25–7.75)

1.63 (0.5–2.25)

− 5.450ǂ

< 0.001

Range

5.25–8.75

0–7.75

MIDAS score

Median (IQR)

31.00 (22.5–44)

2.00 (0–4.5)

− 5.492ǂ

< 0.001

Range

6–57

0–50

MIDAS grade

I

0 (0.0%)

33 (82.5%)

62.280*

< 0.001

II

3 (7.5%)

4 (10.0%)

III

5 (12.5%)

1 (2.5%)

IV

32 (80.0%)

2 (5.0%)

  1. P value > 0.05, non-significant (NS); P value < 0.05, significant (S); P value < 0.001, highly significant (HS)
  2. *Chi-square test
  3. ǂWilcoxon’s rank test